Condition
Thoracic Aortic Aneurysm (TAA)
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed1
Enrolling By Invitation1
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07391293RecruitingPrimary
Genetic Aortic Diseases and Cardiovascular Complications. An Observational Survey of Risk Factors.
NCT06786754Enrolling By Invitation
Fibroblasts and Thoracic Aortic Aneurysms: in Vitro Characterization in With Marfan Syndrome and Genetic Aortic Diseases
NCT06854588Not Yet RecruitingPrimary
POCUS Screening for TAA in Hypertensive Patients in the ED
NCT01480206Completed
Overlay of 3D Scans on Live Fluoroscopy for Endovascular Procedures in the Hybrid OR
Showing all 4 trials